• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在危地马拉用伊维菌素进行盘尾丝虫病社区治疗后的不良反应。

Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala.

作者信息

Zea-Flores R, Richards F O, González-Peralta C, Castro Ramirez J, Zea-Flores G, Collins R C, Cupp E

机构信息

Centro de Investigaciones en Enfermedades Tropicales, Universidad del Valle de Guatemala, Guatemala City.

出版信息

Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):663-6. doi: 10.1016/0035-9203(92)90182-c.

DOI:10.1016/0035-9203(92)90182-c
PMID:1287939
Abstract

Male and female residents on a Guatemalan coffee plantation where Onchocerca volvulus infections were hyperendemic were offered oral ivermectin (100-200 micrograms/kg) as part of a community-wide treatment programme for onchocerciasis. Forty-five persons were treated and then questioned daily for 28 d about changes in their health. Those with complaints were monitored until all signs and symptoms had resolved. Sixty-seven percent complained of some adverse event after treatment; 60% developed observable adverse reactions attributed clinically to ivermectin. No reaction was life-threatening; the most common were oedema (53%) and fever (47%). Expulsion of intestinal helminths was reported by 38%. Almost all reactions began 24-48 h after treatment; their mean duration was 5 d, despite treatment with acetaminophen and antihistamines. Three patients had oedematous changes lasting over 2 weeks. Incidence, but not severity, of reactions was related to the pretreatment density of microfilariae in skin.

摘要

在危地马拉一个盘尾丝虫感染高度流行的咖啡种植园里,为男性和女性居民提供了口服伊维菌素(100 - 200微克/千克),作为社区范围盘尾丝虫病治疗项目的一部分。45人接受了治疗,然后在28天内每天询问他们的健康状况变化。有不适主诉的人接受监测,直到所有体征和症状都消失。67%的人在治疗后抱怨有一些不良事件;60%出现了临床上归因于伊维菌素的可观察到的不良反应。没有反应危及生命;最常见的是水肿(53%)和发热(47%)。38%的人报告肠道蠕虫被排出。几乎所有反应都在治疗后24 - 48小时开始;尽管使用了对乙酰氨基酚和抗组胺药,它们的平均持续时间为5天。3名患者的水肿变化持续超过2周。反应的发生率而非严重程度与皮肤中微丝蚴的治疗前密度有关。

相似文献

1
Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala.在危地马拉用伊维菌素进行盘尾丝虫病社区治疗后的不良反应。
Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):663-6. doi: 10.1016/0035-9203(92)90182-c.
2
Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities.
Am J Trop Med Hyg. 1992 Aug;47(2):156-69. doi: 10.4269/ajtmh.1992.47.156.
3
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.在罗阿丝虫感染流行地区用伊维菌素大规模治疗盘尾丝虫病后的严重反应。
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
4
Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
East Afr Med J. 1994 Dec;71(12):790-1.
5
Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.在由纳氏蚋传播的盘尾丝虫病中,伊维菌素治疗的不良反应。
Am J Trop Med Hyg. 2003 Dec;69(6):621-3.
6
Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment.
Am J Trop Med Hyg. 1993 May;48(5):652-7. doi: 10.4269/ajtmh.1993.48.652.
7
Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.
J Infect Dis. 1991 Feb;163(2):381-5. doi: 10.1093/infdis/163.2.381.
8
Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions.苏丹东部基于社区的伊维菌素分发:可接受性及治疗后早期反应
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):316-8. doi: 10.1016/0035-9203(95)90560-x.
9
Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan.
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):312-5. doi: 10.1016/0035-9203(95)90559-6.
10
Safety of and compliance with community-based ivermectin therapy.基于社区的伊维菌素治疗的安全性与依从性。
Lancet. 1990 Jun 9;335(8702):1377-80. doi: 10.1016/0140-6736(90)91253-7.

引用本文的文献

1
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?非洲的盘尾丝虫病相关皮肤和眼病如何依赖于累计感染和大规模治疗?
PLoS Negl Trop Dis. 2021 Jun 11;15(6):e0009489. doi: 10.1371/journal.pntd.0009489. eCollection 2021 Jun.
2
A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.危地马拉停止盘尾丝虫病伊维菌素群体治疗三年后的知识、态度和实践调查
PLoS Negl Trop Dis. 2016 Jun 24;10(6):e0004777. doi: 10.1371/journal.pntd.0004777. eCollection 2016 Jun.
3
Treatment of onchocerciasis.
盘尾丝虫病的治疗。
Drugs. 1996 Dec;52(6):861-9. doi: 10.2165/00003495-199652060-00007.